Generics 29

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Edoxaban tosylate manufacturers

29 products found

Filters

29 products found

edoxaban tosylate

Tablets, film coated 15 mg, 30 mg, 60 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #519

This pharmaceutical company is a leading manufacturer and exporter with operations spanning over 160 countries, specializing in the development, production, and sale of high-quality generic pharmaceuticals for human use. They have a strong track record of success, having received numerous awards and distinctions including the "European Award for Best Practices" . The company's extensive product portfolio encompasses a wide range of dosage forms and therapy areas, with specific details on these areas, forms, GMP certifications, and patents not provided in the text. Their focus extends beyond prescription medications to include over-the-counter drugs and potentially medical devices or supplements as well.

Manufacturer usually replies in 9 days

edoxaban tosylate

Tablets, film coated 15 mg, 30 mg, 60 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref:Lixiana® (Daiichi Sankyo Europe GmbH)
Manufacturer #10578
This pharmaceutical company, operating for several decades, is a prominent player in the European market. Their core focus is on generic and biosimilar medications, catering to a broad spectrum of healthcare needs. Their product portfolio includes prescription drugs, over-the-counter medications, and health and nutrition supplements. Their offerings are available in various dosage forms, including solids, injectables, and liquids. The company holds a strong track record in the industry, with GMP certifications for their production lines in the EU and North America. They also engage in manufacturing for other pharmaceutical companies. Key therapy areas covered by their products include cardiology, oncology, and women's health. Their dedication to quality and extensive product range position them as a leading force in the pharmaceutical landscape.

Manufacturer usually replies in 13 days

edoxaban tosylate

Tablets, film coated 15 mg, 30 mg, 60 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 14 days

Want to see all 29 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible